Mounjaro, Weight loss

Weight-loss drug Mounjaro will help 'so many' people, say users
Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold privately by clinics and pharmacies.
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
We believe quality journalism should be available to everyone, paid for by those who can afford it. Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period. The National Institute for Health ...
What is Mounjaro? The new NHS weight loss jab with a 12-year wait
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other serious long-term conditions such as diabetes, strokes and heart attacks.
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a magic bullet”.
Who can get new weight-loss jab Mounjaro on the NHS?
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone who meets the criteria to actually receive it,
Mounjaro Lawsuits (2024 Update)
Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
pharmaphorum2d
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
FiercePharma3d
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
devdiscourse3d
NICE Greenlights Mounjaro: A Milestone for Britain's Obesity Battle
NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...
BBC1mon
Nurse’s death linked to approved weight-loss drug
Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September. Her death certificate ...
POLITICAL ROUNDUP: Locals hash over government funding for drugs
Weight-loss drugs are typically not covered by private insurance plans, and in late November, President Joe Biden proposed expanding coverage for these medications for Americans insured by Medicare ...
Eli Lilly CEO says Mounjaro maker may consider other Wisconsin sites for new plants
Fast-growing drugmaker Eli Lilly and Co. would consider Wisconsin sites for new plants beyond a $3 billion project the ...